Dr. Ahmed Bakillah | Diabetes | Best Researcher Award
Research Scientist at King Abdullah International Medical Research Center (KAIMRC),Saudi Arabia
A highly motivated and accomplished scientist with over 30 years of experience in biomedical research, focusing on diabetes, obesity, and cardiovascular diseases. With expertise spanning academia and the pharmaceutical industry, he has contributed significantly to translational medicine, identifying therapeutic targets for metabolic disorders. His leadership in research and editorial roles showcases his commitment to advancing scientific knowledge. Fluent in English, French, and Arabic, he has built strong global research networks. His work integrates cutting-edge biochemical, molecular, and cellular approaches to understand lipid metabolism and diabetes-related complications. His prolific publication record in high-impact journals and involvement in international research collaborations highlight his dedication to scientific excellence.
Education 
Dr. Ahmed Bakillah holds a Doctorate Degree (Sc.D.) in Biochemistry from Chouaib Doukkali University (Morocco) in collaboration with the Medical College of Pennsylvania, awarded with Highest Honor for research on apoB-MTP interaction in lipoprotein metabolism. He earned a Ph.D. in Biochemistry from the University René Descartes of Paris V (France), focusing on Type IV collagen metabolism in diabetic microangiopathy. His Master’s Degree (DEA) in Cell Biology was obtained from the same institution, with a thesis on diabetic microvascular complications. He also earned a Bachelor’s Degree in Cell Biology from the University of Bourgogne (France). His academic background reflects a strong foundation in biochemical and molecular research, particularly in diabetes and metabolic disorders.
work Experience
Dr. Ahmed Bakillah serves as a Research Scientist and Head of Research Academy & Laboratories at King Abdullah International Medical Research Center (KAIMRC-ER, Saudi Arabia). Previously, he was an Assistant Professor & Scientific Director for ECRIP at SUNY Downstate Medical Center (USA), where he led genetic research on cardiovascular diseases in African populations. He has held roles as a Senior Scientist & Research Assistant Professor at SUNY Downstate Medical Center, a Research Investigator at GlaxoSmithKline R&D (USA), and a Principal Scientist at Novo Nordisk A/S (Denmark). His career spans academia, clinical research, and industry, bridging basic and translational science
Research Focus
Dr. Ahmed Bakillah research investigates Type 2 diabetes and vascular complications, therapeutic approaches for obesity and insulin resistance, and the relationship between diabetes and cancer. He explores COVID-19 pathogenesis and cardiovascular complications, employing innovative translational medicine strategies to identify biomarkers for metabolic diseases. His work emphasizes lipid metabolism, lipoprotein abnormalities, and their impact on cardiovascular health.
Awards & Honors🏆
Dr. Ahmed Bakillah accolades include being a Section Editor for JHPN, Guest Editor for Diseases/MDPI, and Managing Editor for Frontiers in Bioscience. He received the NIH Diversity Supplement Re-Entry Award (USA), the GSK Bronze Award for cardiovascular target discovery, and an NIH Postdoctoral Fellowship. He is a long-standing American Heart Association member and has won travel awards from Association Française du Tissu Conjonctif. His recognition includes the Irvine H. Page Arteriosclerosis Research Award and contributions to numerous editorial boards.
Skills 🧠
Dr. Ahmed Bakillah possesses strong expertise in biochemistry, molecular and cellular biology, particularly in diabetes and metabolic diseases. His skills include translational research, drug discovery, and biomarker development. He is adept in project management, scientific writing, peer-reviewing, and journal editorial management. With proficiency in English, French, and Arabic, he excels in scientific communication and collaboration.
Conclusion